Alzamend Neuro Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Alzamend Neuro.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Alzamend Neuro.

Recommendation Trends

Rating	Feb '23	Mar '23
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Initiates $225	Strong Buy	Initiates	$225	+12,262.64%	Apr 12, 2023
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Initiates $1,200	Strong Buy	Initiates	$1,200	+65,834.07%	Oct 1, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-11.00

from -14.70

EPS Next Year

-11.53

from -11.00

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 30, 2020	Apr 30, 2021	Apr 30, 2022	Apr 30, 2023	Apr 30, 2024	Apr 30, 2025	Apr 30, 2026	Apr 30, 2027
Revenue	-	-	-	-	-	-	-	32.18M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-9.28	-10.42	-20.81	-22.89	-14.70	-11.00	-11.53	-2.04
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	33.1M
Avg	n/a	n/a	32.2M
Low	n/a	n/a	30.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-7.67	-5.88	-2.10
Avg	-11.00	-11.53	-2.04
Low	-13.98	-16.66	-1.96

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.